This inventor holds 1 USPTO granted patent. Top assignee: Rohto Pharmaceutical Co., Ltd.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Yukie Akagi: Innovator in Ophthalmic Compositions
Introduction
Yukie Akagi is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of ophthalmology through her innovative research and development of ophthalmic compositions. Her work focuses on creating solutions that minimize side effects while effectively treating eye disorders.
Latest Patents
Yukie Akagi holds a patent for ophthalmic compositions that utilize an adrenergic β receptor agonist with high selectivity toward adrenergic β receptors. This innovative formulation is designed to have negligible side effects on the heart, making it a safer option for patients. The compositions are intended for use as preventives or therapeutics for xerophthalmic disorder and keratoconjunctival disorder. She has 1 patent to her name.
Career Highlights
Yukie Akagi is associated with Rohto Pharmaceutical Co., Ltd., a company known for its commitment to developing effective healthcare solutions. Her work at Rohto has allowed her to focus on advancing ophthalmic treatments that benefit patients worldwide.
Collaborations
Yukie collaborates with notable colleagues, including Yoichi Honma and Ichiro Hirotsu. Their combined expertise contributes to the innovative research and development efforts at Rohto Pharmaceutical Co., Ltd.
Conclusion
Yukie Akagi's contributions to ophthalmic compositions highlight her dedication to improving patient care through innovative solutions. Her work continues to pave the way for advancements in the treatment of eye disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
